Changzhou Qianhong Biopharma Hits Day High with 6.69% Surge

Changzhou Qianhong Biopharma Co., Ltd. has experienced a notable increase of 6.69% on June 29, 2026, reaching an intraday high of CNY 6.44. This performance stands out against the backdrop of the China Shanghai Composite, which only gained 1.16% on the same day. Over the past week, the stock has shown a robust increase of 10.38%, contrasting sharply with the Composite's decline of 2.14%. Despite these short-term gains, the company has faced challenges in its long-term performance metrics. Over the past year, Changzhou Qianhong Biopharma has seen a decline of 24.76%, significantly underperforming the China Shanghai Composite, which has risen by 18.97% during the same period. The company's market capitalization is currently CNY 5,522 million, and it operates within the Pharmaceuticals & Biotechnology sector. Key financial indicators reveal a P/E ratio of 19.00 and a dividend yield of 3.48%. However, net sales have decreased by 20.58% in the most recent quarter, alongside substantial declines in pre-tax and net profits. These figures highlight the ongoing challenges the company faces in maintaining growth and profitability.